APIAM ANIMAL HEALTH LIMITED (AHX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AHX

AHX - APIAM ANIMAL HEALTH LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 4.15
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.415

24 Mar
2025

0.030

OPEN

$0.39

7.79%

HIGH

$0.42

131,631

LOW

$0.39

OTHER COMPANIES IN THE SAME SECTOR
ACL . ALC . BMT . DOC . EBO . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 17/09 - ex-div 1.2c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx2.8
DPS All xxxxxxxxxxxxxxx2.0
Sales/Revenue xxxxxxxxxxxxxxx204.7 M
Book Value Per Share xxxxxxxxxxxxxxx67.8
Net Operating Cash Flow xxxxxxxxxxxxxxx18.9 M
Net Profit Margin xxxxxxxxxxxxxxx2.41 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.11 %
Return on Invested Capital xxxxxxxxxxxxxxx2.32 %
Return on Assets xxxxxxxxxxxxxxx1.97 %
Return on Equity xxxxxxxxxxxxxxx4.11 %
Return on Total Capital xxxxxxxxxxxxxxx5.70 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx12.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx6 M
Long Term Debt xxxxxxxxxxxxxxx96 M
Total Debt xxxxxxxxxxxxxxx102 M
Goodwill - Gross xxxxxxxxxxxxxxx150 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx2 M
Price To Book Value xxxxxxxxxxxxxxx0.51

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx4.9 M
Capex % of Sales xxxxxxxxxxxxxxx2.38 %
Cost of Goods Sold xxxxxxxxxxxxxxx170 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx22 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

24/03/2025

1

Initiation of coverage with Buy

$0.63

51.81%

Canaccord Genuity initiated coverage of Apiam Animal Health with a Buy rating and target price of 63c.

The broker notes more than 60% of the company's revenue comes from companion and mixed animal veterinary clinics where demand is expected to rise once again after the post-Covid slowing.

A key source of demand is expected to come from pets bought during the Covid era that will enter mid-life in 2025-26.

The company recently acquired four clinics which is expected to settle in 4Q25, and the broker is forecasting an FY25 leverage ratio of 2.8x after this settlement.

The broker forecasts 5.4% revenue growth in FY26 and EBITDA growth of 8.7% based on an industry growth of 4.2%. For FY27, the broker forecasts 7.8% EBITDA growth on a 3.8% industry growth estimate.

FORECAST
Canaccord Genuity forecasts a full year FY25 dividend of 2.00 cents and EPS of 3.00 cents.
Canaccord Genuity forecasts a full year FY26 dividend of 2.00 cents and EPS of 4.00 cents.
Access Extra Coverage Research History >

AHX STOCK CHART

FNArena News on AHX

1
Next Week At A Glance – 14-17 Oct 2024

Oct 11 2024 - Weekly Reports
2
Paw Patrol; Investing In Non-Discretionary Pets

Aug 28 2023 - Small Caps
3
Australian Broker Call *Extra* Edition – Mar 10, 2023

Mar 10 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Sep 07, 2022

Sep 07 2022 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Jun 30, 2022

Jun 30 2022 - Daily Market Reports

Latest Healthcare services News

1
The Significance Of Cosmetique’s ASX Listing

Feb 26 2025 - Small Caps
2
Building The No 3 Diagnostic Imaging Player

Jun 19 2024 - Small Caps
3
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
4
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
5
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
6
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
7
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
8
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
9
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
10
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps